Genetic Technologies Limited Sponsored ADR Stock price
Is Genetic Technologies Limited Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
Don't miss a Thing! We will send you all news about Genetic Technologies Limited Sponsored ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
| Head office | Australia |
| CEO | Mr. Morriss |
| Employees | 55 |
| Founded | 1987 |
| Website | genetype.com |


